Neurobo Pharmaceuticals Stock Forecast - Naive Prediction

NRBODelisted Stock  USD 2.36  0.01  0.43%   
The Naive Prediction forecasted value of Neurobo Pharmaceuticals on the next trading day is expected to be 2.57 with a mean absolute deviation of 0.13 and the sum of the absolute errors of 7.68. Neurobo Stock Forecast is based on your current time horizon.
  
A naive forecasting model for Neurobo Pharmaceuticals is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Neurobo Pharmaceuticals value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Neurobo Pharmaceuticals Naive Prediction Price Forecast For the 1st of December

Given 90 days horizon, the Naive Prediction forecasted value of Neurobo Pharmaceuticals on the next trading day is expected to be 2.57 with a mean absolute deviation of 0.13, mean absolute percentage error of 0.02, and the sum of the absolute errors of 7.68.
Please note that although there have been many attempts to predict Neurobo Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Neurobo Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Neurobo Pharmaceuticals Stock Forecast Pattern

Backtest Neurobo PharmaceuticalsNeurobo Pharmaceuticals Price PredictionBuy or Sell Advice 

Neurobo Pharmaceuticals Forecasted Value

In the context of forecasting Neurobo Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Neurobo Pharmaceuticals' downside and upside margins for the forecasting period are 0.02 and 7.39, respectively. We have considered Neurobo Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
2.36
2.57
Expected Value
7.39
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Neurobo Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Neurobo Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria114.3982
BiasArithmetic mean of the errors None
MADMean absolute deviation0.1259
MAPEMean absolute percentage error0.0436
SAESum of the absolute errors7.6772
This model is not at all useful as a medium-long range forecasting tool of Neurobo Pharmaceuticals. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Neurobo Pharmaceuticals. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Neurobo Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Neurobo Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.112.257.07
Details
Intrinsic
Valuation
LowRealHigh
0.122.327.14
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Neurobo Pharmaceuticals. Your research has to be compared to or analyzed against Neurobo Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Neurobo Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Neurobo Pharmaceuticals.

Other Forecasting Options for Neurobo Pharmaceuticals

For every potential investor in Neurobo, whether a beginner or expert, Neurobo Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Neurobo Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Neurobo. Basic forecasting techniques help filter out the noise by identifying Neurobo Pharmaceuticals' price trends.

View Neurobo Pharmaceuticals Related Equities

 Risk & Return  Correlation

Neurobo Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Neurobo Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Neurobo Pharmaceuticals' current price.

Neurobo Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Neurobo Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neurobo Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Neurobo Pharmaceuticals stock market strength indicators, traders can identify Neurobo Pharmaceuticals entry and exit signals to maximize returns.

Neurobo Pharmaceuticals Risk Indicators

The analysis of Neurobo Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Neurobo Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neurobo stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Neurobo Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Neurobo Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving against Neurobo Stock

  0.86BMY Bristol Myers Squibb Sell-off TrendPairCorr
  0.81EWTX Edgewise TherapeuticsPairCorr
  0.78ESPR Esperion Therapeutics Buyout TrendPairCorr
  0.74GILD Gilead SciencesPairCorr
  0.72BHC Bausch Health CompaniesPairCorr
The ability to find closely correlated positions to Neurobo Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Neurobo Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Neurobo Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Neurobo Pharmaceuticals to buy it.
The correlation of Neurobo Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Neurobo Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Neurobo Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Neurobo Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Historical Fundamental Analysis of Neurobo Pharmaceuticals to cross-verify your projections.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Consideration for investing in Neurobo Stock

If you are still planning to invest in Neurobo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobo Pharmaceuticals' history and understand the potential risks before investing.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk